SOPHiA GENETICS SA Reports 2024 AGM Results
Ticker: SOPH · Form: 6-K · Filed: 2024-06-24T00:00:00.000Z
Sentiment: neutral
Topics: agm, corporate-governance, results
TL;DR
SOPHIA GENETICS AGM DONE: Shareholders approved accounts, elected board members, and discharged directors.
AI Summary
SOPHiA GENETICS SA announced the results of its 2024 Annual General Meeting held on June 24, 2024. Key resolutions included the approval of the annual accounts, appropriation of results, and the discharge of the Board of Directors and the auditors. The company also reported on the election of new board members and the reappointment of the statutory auditor.
Why It Matters
The outcomes of the Annual General Meeting are crucial for corporate governance, shareholder confidence, and the company's strategic direction.
Risk Assessment
Risk Level: low — This filing is a routine announcement of AGM results and does not contain new financial or operational risks.
Key Players & Entities
- SOPHiA GENETICS SA (company) — Registrant
- Daan van Well (person) — Chief Legal Officer
- June 24, 2024 (date) — Filing Date and AGM Date
FAQ
What were the main resolutions approved at the 2024 Annual General Meeting?
The main resolutions approved included the adoption of the annual accounts, the appropriation of the results, the discharge of the Board of Directors and the auditors, and the election of board members.
Who signed the report on behalf of SOPHiA GENETICS SA?
The report was signed by Daan van Well, Chief Legal Officer, on behalf of SOPHiA GENETICS SA.
What is the Commission File Number for SOPHiA GENETICS SA?
The Commission File Number for SOPHiA GENETICS SA is 001-40627.
Does SOPHiA GENETICS SA file annual reports under Form 20-F or 40-F?
SOPHiA GENETICS SA files annual reports under cover of Form 20-F.
What is the address of SOPHiA GENETICS SA's principal executive office?
The address of SOPHiA GENETICS SA's principal executive office is La Pièce 12, CH-1180 Rolle, Switzerland.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2024-06-24 11:36:05
Filing Documents
- dp213220_6k.htm (6-K) — 9KB
- dp213220_ex9901.htm (EX-99.1) — 8KB
- image_003.jpg (GRAPHIC) — 0KB
- image_009.jpg (GRAPHIC) — 3KB
- 0000950103-24-008680.txt ( ) — 23KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024. Commission File Number: 001-40627 SOPHiA GENETICS SA (Exact name of registrant as specified in its charter) La Pièce 12 CH-1180 Rolle / VD Switzerland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SOPHiA GENETICS SA Date: June 24, 2024 By: /s/ Daan van Well Name: Daan van Well Title: Chief Legal Officer EXHIBIT INDEX Exhibit No. Description 99.1 Press release SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting